WESTFORD, Mass., July 28, 2015 /PRNewswire/ -- Cynosure, Inc. (Nasdaq: CYNO), which designs, manufactures and markets medical devices for aesthetic procedures and precision surgical applications worldwide, today reported financial results for the three months ended June 30, 2015.
“Our North American business posted another quarter of double-digit growth, as revenues increased 47 percent year-over-year and selling prices remained stable,” said Cynosure Chief Executive Officer Michael Davin. “While our international results reflected the economic slowdowns in Europe and China, as well as unfavorable foreign currency fluctuations, our solid domestic performance enabled us to generate 15 percent overall revenue growth.”
Help employers find you! Check out all the jobs and post your resume.
